Machine learning-based estimation of cognitive performance using regional brain MRI markers: the Northern Manhattan Study.

Journal: Brain imaging and behavior
Published Date:

Abstract

High dimensional neuroimaging datasets and machine learning have been used to estimate and predict domain-specific cognition, but comparisons with simpler models composed of easy-to-measure variables are limited. Regularization methods in particular may help identify regions-of-interest related to domain-specific cognition. Using data from the Northern Manhattan Study, a cohort study of mostly Hispanic older adults, we compared three models estimating domain-specific cognitive performance: sociodemographics and APOE ε4 allele status (basic model), the basic model and MRI markers, and a model with only MRI markers. We used several machine learning methods to fit our regression models: elastic net, support vector regression, random forest, and principal components regression. Model performance was assessed with the RMSE, MAE, and R statistics using 5-fold cross-validation. To assess whether prediction models with imaging biomarkers were more predictive than prediction models built with randomly generated biomarkers, we refit the elastic net models using 1000 datasets with random biomarkers and compared the distribution of the RMSE and R in models using these random biomarkers to the RMSE and R from observed models. Basic models explained ~ 31-38% of the variance in domain-specific cognition. Addition of MRI markers did not improve estimation. However, elastic net models with only MRI markers performed significantly better than random MRI markers (one-sided P < .05) and yielded regions-of-interest consistent with previous literature and others not previously explored. Therefore, structural brain MRI markers may be more useful for etiological than predictive modeling.

Authors

  • Michelle R Caunca
    Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Lily Wang
    Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Ying Kuen Cheung
    Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Noam Alperin
    Department of Radiology, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Sang H Lee
    Department of Radiology, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Mitchell S V Elkind
    Department of Neurology (A.K.B., M.S.V.E.), College of Physicians and Surgeons, Columbia University; Department of Epidemiology (A.K.B., M.S.V.E.), Mailman School of Public Health, Columbia University, New York, NY; Wake Forest University (M.E.C., C.D.L.), NC; Department of Neurology (A.L.), New York University School of Medicine; Department of Neurology and Rehabilitation Medicine (C.J.M., J.O., D.W.), University of Cincinnati, OH; Departments of Anesthesiology and Neurology (M.L.J.), Duke University, Durham, NC; Baylor University, Houston, TX (S.M.); and University of Illinois Chicago (F.D.T.).
  • Ralph L Sacco
    Evelyn F. McKnight Brain Institute, University of Miami, Miami, FL, USA.
  • Clinton B Wright
    National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
  • Tatjana Rundek
    Evelyn F. McKnight Brain Institute, University of Miami, Miami, FL, USA. trundek@med.miami.edu.